Q2 2025 Holdings
Filed 2025-08-14 | 13 holdings | $154.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beta Bionics Inc.(BBNX) | Common Stock | 08659B102 | $28.9M | 1,988,287 | 18.7% |
| Kestra Med Technologies Ltd.(KMTS) | Common Stock | G52441105 | $27.3M | 1,645,893 | 17.7% |
| Upstream Bio Inc.(UPB) | Common Stock | 91678A107 | $22.4M | 2,036,293 | 14.5% |
| Nuvation Bio(NUVB) | Common Stock Class A | 67080N101 | $21.5M | 11,042,728 | 13.9% |
| Bicara Therapeutics Inc.(BCAX) | Common Stock | 055477103 | $20.5M | 2,204,650 | 13.3% |
| Replimune Group(REPL) | Common Stock | 76029N106 | $18.3M | 1,975,203 | 11.9% |
| Lexeo Therapeutics(LXEO) | Common Stock | 52886X107 | $4.8M | 1,184,636 | 3.1% |
| Ikena Oncology | Common Stock | 45175G108 | $3.0M | 2,249,123 | 2.0% |
| Sana Biotechnology, Inc.(SANA) | Common Stock | 799566104 | $2.3M | 843,750 | 1.5% |
| Alumis Inc.(ALMS) | Common Stock | 022307102 | $2.0M | 653,223 | 1.3% |
| enGene Holdings Inc.(ENGN) | Common Stock | 29286M105 | $1.9M | 526,357 | 1.2% |
| Immunic Inc.(IMUX) | Common Stock | 4525EP101 | $1.2M | 1,788,160 | 0.8% |
| enGene Holdings Inc.(ENGNW) | Warrant | 29286M113 | $273.0K | 321,502 | 0.2% |